- Corporate Officers - C
- Countouriotis Athena
Insider Trading History of Countouriotis Athena
The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Countouriotis Athena since 2016.
This trader's CIK number is 1571469.
At the time of last reporting, Countouriotis Athena was the President & CEO of Turning Point Therapeutics, Inc.. (stock ticker symbol TPTX).
Also see all insider trading activities at Turning Point Therapeutics, Inc..
Note that in the past
Countouriotis Athena also reported insider trading activities as an insider of the following companies:
Yearly summary of insider trading at Turning Point Therapeutics, Inc. (TPTX) by Countouriotis Athena
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2022 | TPTX | 0 | $0 | 2,971 | $107,847 | 0 | $0 |
| 2021 | TPTX | 0 | $0 | 60,000 | $8,248,661 | 60,000 | $191,999 |
| 2020 | TPTX | 4,166 | $249,960 | 0 | $0 | 0 | $0 |
| 2019 | TPTX | 22,000 | $666,000 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Passage Bio, Inc. (PASG) by Countouriotis Athena
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2020 | PASG | 18,900 | $309,950 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Halozyme Therapeutics, Inc. (HALO) by Countouriotis Athena
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2017 | HALO | 0 | $0 | 0 | $0 | 25,996 | $0 |
| 2016 | HALO | 0 | $0 | 0 | $0 | 13,950 | $0 |
Insider trading activities at 3 companies by Countouriotis Athena:
1. Turning Point Therapeutics, Inc. (TPTX)
2. Passage Bio, Inc. (PASG)
3. Halozyme Therapeutics, Inc. (HALO)
Table 1. Insider trading of Turning Point Therapeutics, Inc. (TPTX) by Countouriotis Athena
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2022-02-09 | TPTX | Sale | 2,971 | 36.30 | 107,847 |
| 2021-02-09 | TPTX | Option Ex | 25,666 | 3.20 | 82,131 |
| 2021-02-10 | TPTX | Option Ex | 25,392 | 3.20 | 81,254 |
| 2021-02-11 | TPTX | Option Ex | 8,942 | 3.20 | 28,614 |
| 2021-02-09 | TPTX | Sale | 25,666 | 138.49 | 3,554,535 |
| 2021-02-10 | TPTX | Sale | 25,392 | 136.43 | 3,464,128 |
| 2021-02-11 | TPTX | Sale | 8,942 | 137.55 | 1,229,998 |
| 2020-05-21 | TPTX | Buy | 4,166 | 60.00 | 249,960 |
| 2019-09-10 | TPTX | Buy | 10,000 | 45.00 | 450,000 |
| 2019-04-22 | TPTX | Buy | 12,000 | 18.00 | 216,000 |
Table 2. Insider trading of Passage Bio, Inc. (PASG) by Countouriotis Athena
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2020-03-24 | PASG | Buy | 10,000 | 14.97 | 149,750 |
| 2020-03-03 | PASG | Buy | 8,900 | 18.00 | 160,200 |
Table 3. Insider trading of Halozyme Therapeutics, Inc. (HALO) by Countouriotis Athena
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2017-02-03 | HALO | Option Ex | 18,496 | .00 | 0 |
| 2017-01-05 | HALO | Option Ex | 7,500 | .00 | 0 |
| 2016-06-30 | HALO | Option Ex | 6,450 | .00 | 0 |
| 2016-01-05 | HALO | Option Ex | 7,500 | .00 | 0 |
Insider trading activities including stock purchases, stock sales, and option exercises
listed in the above table cannot be completely guaranteed as to their accuracy.
For more information regarding the trades made by Countouriotis Athena
(President & CEO of Turning Point Therapeutics, Inc. at the time of this reporting) see
the Securities and Exchange Commission (SEC) website.